Media Advisory - Announcement of a multi-million dollar expansion of personalized medicine platform to New Brunswick

MONCTON, NB, April 13, 2016 /CNW Telbec/ - Members of the media are invited to attend an important announcement regarding a multi-million dollar investment that will strengthen New Brunswick's personalized medicine capabilities and extend Exactis Innovation's network to Atlantic Canada.

Government officials, research institute representatives and industry leaders will be coming together on April 18 at 11:00 a.m. to announce this collaborative partnership that will help drive new breakthroughs in the field of cancer research.




Press conference announcing a multi-million dollar investment in New Brunswick


The Honourable Brian Gallant, Premier, New Brunswick
The Honourable Victor Boudreau, Minister of Health, New Brunswick
Mr. Chirfi Guindo, President and Managing Director, Merck Canada Inc.
Mr. Andy Chabot, President and CEO, Cancer Research Society (CRS)
Dr. Bruno Battistini, President and CEO – Scientific Director, New Brunswick Health Research Foundation (NBHRF)
Dr. Gerald Batist, Co-Founder and Scientific Director of Exactis Innovation and Q-CROC, and Director, Segal Cancer Centre at the Jewish General Hospital
Dr. Rodney Ouellette, President and Scientific Director, Atlantic Cancer Research Institute (ACRI)


Monday, April 18, 2016
11:00 a.m.


Dr. Georges-L.-Dumont University Hospital Centre 
Terrasse B, 2nd floor
330 Université Ave.
Moncton, NB  E1C 2Z3


SOURCE Merck Canada Inc.

For further information: Jane Bardsley, Office: 506-672-1860 extension 8334, Cell: 506-333-5164,


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890